| Bioactivity | Anticancer agent 183 (example 48) is a non-agonistic PPARG modulator. Anticancer agent 183 has a high affinity to PPARG (PPARγ). Anticancer agent 183 inhibits kinase-mediated phosphorylation of PPARG. Anticancer agent 183 can used for research on metabolic diseases to avoid side effects[1]. |
| Name | PPARγ modulator-1 |
| CAS | 1415321-54-8 |
| Formula | C34H40N2O4 |
| Molar Mass | 540.69 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Theodore Mark Kamenecka, et al. N-benzylindole modulators of pparg. 2012. |
PPARγ modulator-1
CAS: 1415321-54-8 F: C34H40N2O4 W: 540.69
Anticancer agent 183 (example 48) is a non-agonistic PPARG modulator. Anticancer agent 183 has a high affinity to PPARG
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.